Lexicon Pharmaceuticals, Inc.
LXRXNasdaqCIK 1062822HealthcareFiscal year ends Dec 31
Reports and events: 314 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001062822-26-000117 |
| 2026-08-0607:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-26-000112 |
| 2026-05-0821:42 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-215295 |
| 2026-05-0716:21 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001062822-26-000101 |
| 2026-05-0707:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-26-000098 |
| 2026-05-0616:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062822-26-000094 |
| 2026-04-3016:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001062822-26-000065 |
| 2026-03-1616:03 ET | DEF 14A | Proxy statementPeriod 2026-03-16 | 0001062822-26-000056 |
| 2026-03-0516:50 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001062822-26-000050 |
| 2026-03-0507:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-26-000047 |
| 2026-02-0221:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-034176 |
| 2026-02-0216:49 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-033793 |
| 2026-01-2916:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-029514 |
| 2025-11-1016:31 ET | 8-K | 8.01 Other events | 0001193125-25-274383 |
| 2025-11-0616:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-270020 |
| 2025-11-0616:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001062822-25-000054 |
| 2025-11-0607:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-25-000049 |
| 2025-08-0616:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-038340 |
| 2025-08-0607:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-25-000042 |
| 2025-07-2807:36 ET | 8-K | 8.01 Other events | 0001062822-25-000037 |
| 2025-07-0309:10 ET | 8-K | 8.01 Other events | 0001062822-25-000035 |
| 2025-06-0316:04 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001062822-25-000033 |
| 2025-05-1407:08 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001062822-25-000029 |
| 2025-05-1316:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-25-000027 |
| 2025-04-2207:07 ET | DEF 14A | Proxy statementPeriod 2025-04-22 | 0001062822-25-000023 |
| 2025-03-2807:59 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001062822-25-000019 |
| 2025-03-0716:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001062822-25-000013 |
| 2025-03-0616:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-25-000008 |
| 2025-01-0716:08 ET | 8-K | 3.01 Delisting notice | 0001062822-25-000005 |
| 2025-01-0216:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062822-25-000003 |
| 2024-12-0921:33 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-273713 |
| 2024-11-2216:05 ET | 8-K | 2.05 Exit or disposal costs | 0001062822-24-000064 |
| 2024-11-2016:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062822-24-000062 |
| 2024-11-1307:12 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001062822-24-000060 |
| 2024-11-1216:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-24-000057 |
| 2024-10-1616:37 ET | 8-K | 1.01 Entry into a material agreement | 0001062822-24-000054 |
| 2024-09-1606:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062822-24-000051 |
| 2024-08-0207:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001062822-24-000046 |
| 2024-08-0116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-24-000043 |
| 2024-07-2917:44 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-187770 |
| 2024-07-0809:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062822-24-000036 |
| 2024-07-0116:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001062822-24-000032 |
| 2024-05-1417:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-138357 |
| 2024-05-1016:15 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001062822-24-000029 |
| 2024-05-0216:08 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001062822-24-000024 |
| 2024-05-0216:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062822-24-000023 |
| 2024-04-2909:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001062822-24-000020 |
| 2024-03-2607:05 ET | DEF 14A | Proxy statementPeriod 2024-03-25 | 0001062822-24-000014 |
| 2024-03-2516:00 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001062822-24-000008 |
| 2024-03-1321:20 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-067142 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.